1 | canada i am a | | | | | | | 2 | 0.27% |
2 | janssen inc medical information | | | | | | | 2 | 0.27% |
3 | i am a us | | | | | | | 2 | 0.27% |
4 | your use of this | | | | | | | 2 | 0.27% |
5 | notice and privacy policy | | | | | | | 2 | 0.27% |
6 | and privacy policy of | | | | | | | 2 | 0.27% |
7 | a healthcare professional in | | | | | | | 2 | 0.27% |
8 | information mondayfriday 830 am | | | | | | | 2 | 0.27% |
9 | site is intended for | | | | | | | 2 | 0.27% |
10 | medical information mondayfriday 830 | | | | | | | 2 | 0.27% |
11 | janssen medical information mondayfriday | | | | | | | 2 | 0.27% |
12 | medical affairs platform for | | | | | | | 2 | 0.27% |
13 | affairs platform for canadian | | | | | | | 2 | 0.27% |
14 | the janssen inc medical | | | | | | | 2 | 0.27% |
15 | notice please see our | | | | | | | 1 | 0.14% |
16 | please see our privacy | | | | | | | 1 | 0.14% |
17 | see our privacy policy | | | | | | | 1 | 0.14% |
18 | policy velcade® is a | | | | | | | 1 | 0.14% |
19 | our privacy policy velcade® | | | | | | | 1 | 0.14% |
20 | privacy policy velcade® is | | | | | | | 1 | 0.14% |
21 | is subject to our | | | | | | | 1 | 0.14% |
22 | velcade® is a trademark | | | | | | | 1 | 0.14% |
23 | is a trademark of | | | | | | | 1 | 0.14% |
24 | millennium pharmaceuticals inc this | | | | | | | 1 | 0.14% |
25 | pharmaceuticals inc this site | | | | | | | 1 | 0.14% |
26 | inc this site was | | | | | | | 1 | 0.14% |
27 | legal notice please see | | | | | | | 1 | 0.14% |
28 | information on this site | | | | | | | 1 | 0.14% |
29 | site is subject to | | | | | | | 1 | 0.14% |
30 | inc which is solely | | | | | | | 1 | 0.14% |
31 | professionals from canada only | | | | | | | 1 | 0.14% |
32 | and is published by | | | | | | | 1 | 0.14% |
33 | is published by janssen | | | | | | | 1 | 0.14% |
34 | published by janssen inc | | | | | | | 1 | 0.14% |
35 | by janssen inc which | | | | | | | 1 | 0.14% |
36 | janssen inc which is | | | | | | | 1 | 0.14% |
37 | which is solely responsible | | | | | | | 1 | 0.14% |
38 | this site is subject | | | | | | | 1 | 0.14% |
39 | is solely responsible for | | | | | | | 1 | 0.14% |
40 | solely responsible for its | | | | | | | 1 | 0.14% |